Sitryx Therapeutics

Recent Finacing

Equity

Recent Raise

$39M

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.